A detailed history of Karani Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Karani Asset Management LLC holds 24,330 shares of NVO stock, worth $2.13 Million. This represents 3.2% of its overall portfolio holdings.

Number of Shares
24,330
Previous 24,830 2.01%
Holding current value
$2.13 Million
Previous $4.02 Million 44.95%
% of portfolio
3.2%
Previous 4.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$90.94 - $199.54 $45,470 - $99,770
-500 Reduced 2.01%
24,330 $2.21 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $773,130 - $929,695
-5,842 Reduced 19.05%
24,830 $3.95 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $1.22 Million - $1.6 Million
-11,850 Reduced 27.87%
30,672 $4.15 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $58,597 - $71,911
615 Added 1.47%
42,522 $4.24 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $1.45 Million - $1.71 Million
-14,058 Reduced 25.12%
41,907 $4.67 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $640,248 - $773,937
6,877 Added 14.01%
55,965 $6.22 Million
Q4 2021

Nov 23, 2022

BUY
$95.88 - $117.08 $11,313 - $13,815
118 Added 0.24%
49,060 $5.5 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $11,313 - $13,815
118 Added 0.24%
49,088 $5.5 Million
Q3 2021

Nov 23, 2022

BUY
$84.42 - $106.62 $61,626 - $77,832
730 Added 1.51%
48,942 $4.7 Million
Q3 2021

Nov 08, 2021

BUY
$84.42 - $106.62 $63,990 - $80,817
758 Added 1.57%
48,970 $4.7 Million
Q2 2021

Nov 23, 2022

BUY
$67.66 - $84.76 $21,583 - $27,038
319 Added 0.67%
48,212 $4.04 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $23,478 - $29,411
347 Added 0.72%
48,212 $4.04 Million
Q1 2021

Nov 23, 2022

BUY
$67.06 - $75.82 $102,467 - $115,852
1,528 Added 3.3%
47,893 $3.23 Million
Q1 2021

May 12, 2021

BUY
$67.06 - $75.82 $100,590 - $113,729
1,500 Added 3.24%
47,865 $3.23 Million
Q4 2020

Nov 23, 2022

SELL
$63.89 - $73.8 $424,868 - $490,770
-6,650 Reduced 12.54%
46,365 $3.24 Million
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $424,868 - $490,770
-6,650 Reduced 12.54%
46,365 $3.24 Million
Q2 2020

Nov 23, 2022

SELL
$58.54 - $67.94 $237,087 - $275,157
-4,050 Reduced 7.1%
53,015 $3.47 Million
Q2 2020

Aug 05, 2020

SELL
$58.54 - $67.94 $237,087 - $275,157
-4,050 Reduced 7.1%
53,015 $3.47 Million
Q1 2020

Nov 23, 2022

BUY
$49.46 - $64.78 $774,790 - $1.01 Million
15,665 Added 37.84%
57,065 $3.44 Million
Q1 2020

Apr 30, 2020

BUY
$49.46 - $64.78 $774,790 - $1.01 Million
15,665 Added 37.84%
57,065 $3.44 Million
Q4 2019

Nov 23, 2022

SELL
$49.86 - $58.26 $55,942 - $65,367
-1,122 Reduced 2.64%
41,400 $2.4 Million
Q4 2019

Jan 27, 2020

BUY
$49.86 - $58.26 $2.06 Million - $2.41 Million
41,400 New
41,400 $2.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Karani Asset Management LLC Portfolio

Follow Karani Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karani Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Karani Asset Management LLC with notifications on news.